Rubinstein, J. D., Zhu, X., Lutzko, C., Leemhuis, T., Cancelas, J. A., Jodele, S., . . . Nelson, A. S. (2020). Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy. Blood Adv.
Styl ChicagoRubinstein, Jeremy D., et al. "Complement Inhibition Does Not Impair the Clinical Antiviral Capabilities of Virus-specific T-cell Therapy." Blood Adv 2020.
Citace podle MLARubinstein, Jeremy D., et al. "Complement Inhibition Does Not Impair the Clinical Antiviral Capabilities of Virus-specific T-cell Therapy." Blood Adv 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..